feifukang

herbal preparation consisting of Astragalus membranaceus, Codonopsis pilosula, Ophiopogon japonicus, Schisandra chinensis, Panax notoginseng, Bulbus fritillariae thunbergii, Rhizoma anemarrhenae, and Glycyrrhiza uralensis; used to treat pulmonary fibrosis and inhibits JAK-STAT signaling pathway

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - Chinese Herbal Drugs: 73
        feifukang: 1
Pharmaceutical Preparations
- Chinese Herbal Drugs: 73
  - feifukang: 1

Experts

1.	Li, Hongbo: 1 article (08/2018)
2.	Lv, Changjun: 1 article (08/2018)
3.	Song, Xiaodong: 1 article (08/2018)
4.	Wang, Youlei: 1 article (08/2018)
5.	Wang, Zhenkai: 1 article (08/2018)
6.	Yu, Chen: 1 article (08/2018)
7.	Zhang, Jie: 1 article (08/2018)
8.	Zhang, Jinjin: 1 article (08/2018)

Related Diseases

1.	Pulmonary Fibrosis (Fibrosing Alveolitis) 08/09/2018 - "Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway."